Suchergebnisse - "Troya, Jesús"

PubPharm (92)

1

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

enthalten in: bioRxiv.org | 2024

von Matuozzo, D. | Talouarn, E. | Marchal, A. | +115

2

Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs : A Real-World Study

enthalten in: Infectious diseases and therapy | 2024

von Ambrosioni, J. | Díaz, N. | Marzolini, C. | +12

3

Reasons against routine determination of plasma trough levels in PWH treated with intramuscular long acting cabotegravir and rilpivirine as of today

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Buzón-Martín, L. | Troya, J.

4

Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48-96 weeks of RETROBIC Study

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Troya, J. | Pousada, G. | Micán, R. | +10

5

Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study

enthalten in: Infectious diseases and therapy | 2024

von Ambrosioni, J. | Díaz, N. | Marzolini, C. | +12

6

Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

enthalten in: The Journal of experimental medicine | 2024

von Bastard, P. | Gervais, A. | Taniguchi, M. | +187

7

Correction : Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

enthalten in: Genome medicine | 2024

von Matuozzo, D. | Talouarn, E. | Marchal, A. | +106

ErratumFor: Genome Med. 2023 Apr 5;15(1):22. - PMID 37020259

8

Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

enthalten in: Genome medicine | 2024

von Matuozzo, D. | Talouarn, E. | Marchal, A. | +118

9

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

enthalten in: Science immunology | 2023

von Bastard, P. | Vazquez, S. | Liu, J. | +98

10

Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Podzamczer, D. | Imaz, A. | Lopez-Lirola, A. | +25

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]